American Cryostem (CRYO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRYO Annual Balance Sheets →
Balance sheet data covering American Cryostem–Jun 30 2021 offers a view into how Jun 30 2022's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2022)
(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Assets
Cash & cash equivalent0.00
Security Deposit0.01
Cash & Short-term Investments0.00
Accounts receivable0.01
Inventories0.02
Other Current Assets0.03
Prepaid Expense, Current AS0.04
Total Current Assets0.12
Equipment/Property/Plant Net0.00
Intangible Assets0.43
Other Assets, Noncurrent0.51
Assets Net0.10
Total Assets1.06
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.38
Accrued Salaries1.24
Estimated Litigation Liability, Current0.12
Loans Payable, Current NO0.02
Deferred Revenue DE0.03
Total Current Liabilities1.79
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Due to Affiliate, Noncurrent1.14
Total Liabilities2.93
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock19.10
Retained Earnings / Accumulated Deficit-21.02
Other Equity0.00
Common Stockholder's Equity-1.88
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-1.88
Liabilities & Stockholder's Equity1.06
4 historic quarters locked

Sign in to unlock the full American Cryostem balance sheet history.

About American Cryostem Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001019056-22-000573

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.